Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 9 Breast Neoplasms 7 Neoplasms 4 Fatigue 3 Recurrence 2 Body Weight 2 Weight Loss 1 Warts 1 Vomiting 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nausea 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Insulin Resistance 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Dementia 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Asthenia 1 Anomia 1 Alzheimer Disease 1

Interventions

N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2 2-Propanol 2 methyl 5-aminolevulinate 1 Zinc Sulfate 1 Vaccination 1 VP-102 1 Tuberculin 1 Photochemotherapy 1 PRA1 protein, Candida albicans 1 Exercise 1 Cantharidin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Warts × Exercise × Clear all

NCT03691831 2020-10-27

A Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed

502 enrolled 22 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡